Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nigella sativa in hemodialysis patients with diabetes
IRCT20200411047027N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2020
- Countries
- 1
01
Overview
Phase 3 trial of nigella sativa in type 2 diabetes mellitus (T2DM) and end-stage kidney disease (ESKD), sponsored by Tabriz University of Medical Sciences. Started May 2020; status: completed.
02
Drugs
nigella sativa
03
Conditions
type 2 diabetes mellitus (T2DM)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT20200411047027N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200411047027N1.